The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Martine Gilard, Michael Schlüter, Thomas M. Snow, Gianni Dall'Ara, Helene Eltchaninoff, Neil Moat, Javier Goicolea, Gian Paolo Ussia, Petr Kala, Peter Wenaweser, Marian Zembala, Georg Nickenig, Susanna Price, Eduardo Alegria Barrero, Bernard Iung, Pepe Zamorano, Gerhard Schuler, Roberto Corti, Ottavio Alfieri, Bernard PrendergastPeter Ludman, Stephan Windecker, Manel Sabate, Adam Witkowski, Haim Danenberg, Erwin Schroeder, Francesco Romeo, Carlos Macaya, Geneviève Derumeaux, Cécile Laroche, Michele Pighi, Roberta Serdoz, Carlo Di Mario

Research output: Contribution to journalArticle

Abstract

Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4±7.2 years, 2,291 [50.1%] male) receiving TAVI with the SAPIEN XT (57.3%) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90%) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88%). One-year survival based on 4,564 patients was estimated at 79.1%. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4% survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unselected elderly patients.

Original languageEnglish
Pages (from-to)79-87
Number of pages9
JournalEuroIntervention
Volume12
Issue number1
DOIs
Publication statusPublished - May 1 2016

Fingerprint

Registries
Survival
Lost to Follow-Up
Transcatheter Aortic Valve Replacement
cyhalothrin
Atrial Fibrillation
Chronic Obstructive Pulmonary Disease
Prostheses and Implants
Blood Vessels
Mortality

Keywords

  • Aortic stenosis
  • Registry
  • Survival
  • Transcatheter aortic valve implantation (TAVI)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation : 12-month clinical outcomes. / Gilard, Martine; Schlüter, Michael; Snow, Thomas M.; Dall'Ara, Gianni; Eltchaninoff, Helene; Moat, Neil; Goicolea, Javier; Ussia, Gian Paolo; Kala, Petr; Wenaweser, Peter; Zembala, Marian; Nickenig, Georg; Price, Susanna; Barrero, Eduardo Alegria; Iung, Bernard; Zamorano, Pepe; Schuler, Gerhard; Corti, Roberto; Alfieri, Ottavio; Prendergast, Bernard; Ludman, Peter; Windecker, Stephan; Sabate, Manel; Witkowski, Adam; Danenberg, Haim; Schroeder, Erwin; Romeo, Francesco; Macaya, Carlos; Derumeaux, Geneviève; Laroche, Cécile; Pighi, Michele; Serdoz, Roberta; Di Mario, Carlo.

In: EuroIntervention, Vol. 12, No. 1, 01.05.2016, p. 79-87.

Research output: Contribution to journalArticle

Gilard, M, Schlüter, M, Snow, TM, Dall'Ara, G, Eltchaninoff, H, Moat, N, Goicolea, J, Ussia, GP, Kala, P, Wenaweser, P, Zembala, M, Nickenig, G, Price, S, Barrero, EA, Iung, B, Zamorano, P, Schuler, G, Corti, R, Alfieri, O, Prendergast, B, Ludman, P, Windecker, S, Sabate, M, Witkowski, A, Danenberg, H, Schroeder, E, Romeo, F, Macaya, C, Derumeaux, G, Laroche, C, Pighi, M, Serdoz, R & Di Mario, C 2016, 'The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes', EuroIntervention, vol. 12, no. 1, pp. 79-87. https://doi.org/10.4244/EIJV12I1A15
Gilard, Martine ; Schlüter, Michael ; Snow, Thomas M. ; Dall'Ara, Gianni ; Eltchaninoff, Helene ; Moat, Neil ; Goicolea, Javier ; Ussia, Gian Paolo ; Kala, Petr ; Wenaweser, Peter ; Zembala, Marian ; Nickenig, Georg ; Price, Susanna ; Barrero, Eduardo Alegria ; Iung, Bernard ; Zamorano, Pepe ; Schuler, Gerhard ; Corti, Roberto ; Alfieri, Ottavio ; Prendergast, Bernard ; Ludman, Peter ; Windecker, Stephan ; Sabate, Manel ; Witkowski, Adam ; Danenberg, Haim ; Schroeder, Erwin ; Romeo, Francesco ; Macaya, Carlos ; Derumeaux, Geneviève ; Laroche, Cécile ; Pighi, Michele ; Serdoz, Roberta ; Di Mario, Carlo. / The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation : 12-month clinical outcomes. In: EuroIntervention. 2016 ; Vol. 12, No. 1. pp. 79-87.
@article{a2e59799a593401ebcf5a4b359670304,
title = "The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes",
abstract = "Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4±7.2 years, 2,291 [50.1{\%}] male) receiving TAVI with the SAPIEN XT (57.3{\%}) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90{\%}) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88{\%}). One-year survival based on 4,564 patients was estimated at 79.1{\%}. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4{\%} survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unselected elderly patients.",
keywords = "Aortic stenosis, Registry, Survival, Transcatheter aortic valve implantation (TAVI)",
author = "Martine Gilard and Michael Schl{\"u}ter and Snow, {Thomas M.} and Gianni Dall'Ara and Helene Eltchaninoff and Neil Moat and Javier Goicolea and Ussia, {Gian Paolo} and Petr Kala and Peter Wenaweser and Marian Zembala and Georg Nickenig and Susanna Price and Barrero, {Eduardo Alegria} and Bernard Iung and Pepe Zamorano and Gerhard Schuler and Roberto Corti and Ottavio Alfieri and Bernard Prendergast and Peter Ludman and Stephan Windecker and Manel Sabate and Adam Witkowski and Haim Danenberg and Erwin Schroeder and Francesco Romeo and Carlos Macaya and Genevi{\`e}ve Derumeaux and C{\'e}cile Laroche and Michele Pighi and Roberta Serdoz and {Di Mario}, Carlo",
year = "2016",
month = "5",
day = "1",
doi = "10.4244/EIJV12I1A15",
language = "English",
volume = "12",
pages = "79--87",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "1",

}

TY - JOUR

T1 - The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation

T2 - 12-month clinical outcomes

AU - Gilard, Martine

AU - Schlüter, Michael

AU - Snow, Thomas M.

AU - Dall'Ara, Gianni

AU - Eltchaninoff, Helene

AU - Moat, Neil

AU - Goicolea, Javier

AU - Ussia, Gian Paolo

AU - Kala, Petr

AU - Wenaweser, Peter

AU - Zembala, Marian

AU - Nickenig, Georg

AU - Price, Susanna

AU - Barrero, Eduardo Alegria

AU - Iung, Bernard

AU - Zamorano, Pepe

AU - Schuler, Gerhard

AU - Corti, Roberto

AU - Alfieri, Ottavio

AU - Prendergast, Bernard

AU - Ludman, Peter

AU - Windecker, Stephan

AU - Sabate, Manel

AU - Witkowski, Adam

AU - Danenberg, Haim

AU - Schroeder, Erwin

AU - Romeo, Francesco

AU - Macaya, Carlos

AU - Derumeaux, Geneviève

AU - Laroche, Cécile

AU - Pighi, Michele

AU - Serdoz, Roberta

AU - Di Mario, Carlo

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4±7.2 years, 2,291 [50.1%] male) receiving TAVI with the SAPIEN XT (57.3%) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90%) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88%). One-year survival based on 4,564 patients was estimated at 79.1%. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4% survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unselected elderly patients.

AB - Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4±7.2 years, 2,291 [50.1%] male) receiving TAVI with the SAPIEN XT (57.3%) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90%) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88%). One-year survival based on 4,564 patients was estimated at 79.1%. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4% survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unselected elderly patients.

KW - Aortic stenosis

KW - Registry

KW - Survival

KW - Transcatheter aortic valve implantation (TAVI)

UR - http://www.scopus.com/inward/record.url?scp=84969514588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969514588&partnerID=8YFLogxK

U2 - 10.4244/EIJV12I1A15

DO - 10.4244/EIJV12I1A15

M3 - Article

AN - SCOPUS:84969514588

VL - 12

SP - 79

EP - 87

JO - EuroIntervention

JF - EuroIntervention

SN - 1774-024X

IS - 1

ER -